Daytime sleepiness is a common complaint in blind subjects. Abnormally timed melatonin has been invoked as a possible cause of both daytime sleepiness and nighttime awakening. In free-running blind individuals, there is an opportunity to assess the relationship between endogenous melatonin rhythms and subjective sleepiness and naps. The aim of this study was to characterize melatonin rhythms and simultaneously to evaluate subjective napping. A total of 15 subjects with no conscious light perception (NPL) were studied for 1 month. Prior to the study, sleep disorders were assessed using the Pittsburgh Sleep Quality Index. Cosinor and regression analysis revealed that 9 of the 15 NPL subjects had free-running 6-sulphatoxymelatonin (aMT6s) rhythms (period [&tau;] range = 24.34 to 24.79 h), 3 were entrained with an abnormal phase, and 3 were normally entrained. Most of the subjects (13 of 15) had daytime naps; the 2 individuals who did not made conscious efforts not to do so. Subjects with abnormal aMT6s rhythms had more naps of a longer duration than did those with normal rhythms. Free-running nap rhythms occurred only in subjects with free-running aMT6s rhythms. The 2 abnormally entrained subjects who napped did so at times that coincided with high levels of aMT6s (mean aMT6s acrophase [phi] &plusmn; SD = 14.30 &plusmn; 1.08 h, 20.30 &plusmn; 0.62 h; mean nap time &plusmn; SD = 14.01 & p l u s m n ; 3.60 h, 18.23 &plusmn; 3.20 h, respectively). Regardless of aMT6s rhythm abnormality, significantly more naps occurred within a 4-h period before and after the estimated aMT6s acrophase. In 4 free-running subjects, aMT6s acrophase (phi) passed through an entire 24-h period. When aMT6s was in a normal phase position (24:00 to 06:00 h), night-sleep duration tended to increase with a significant reduction in the number and duration of naps. Sleep onset and offset times tended to advance and delay as the aMT6s rhythms advanced and delayed. Our results show a striking relationship between the timing of daytime production of melatonin and the timing of daytime naps. This suggests that abnormally timed endogenous melatonin may induce sleepiness in blind subjects.
INTRODUCTION
Sleep disorder is a common complaint in the blind community (Martens et al., 1990; Sasaki et al., 1992; Tabandeh et al., 1995) , and daytime sleepiness is a primary reason for this complaint Lewy and Newsome, 1983; Sack et al., 1987) . In a broad sense, it has been attributed to a disorganization of the circadian system due to a lack of synchronization by light, the major environmental zeitgeber in humans (Czeisler et al., 1981 ; Wever, 1979) enabling the endogenous body clock and the rhythms it controls to run at their endogenous period, usually greater than 24 h (Wever, 1979) . Daytime sleepiness or naps are a particular problem in the blind (e.g., Sack et al., 1991 Sack et al., , 1992 Stavosky et al., 1980) , especially in the working environment, with associated reduced alertness and performance. More specifically, daytime sleepiness has been said to reflect the free-running rhythms of cortisol , melatonin Sack et al.,1987; Tzischinsky et al., 1991) , temperature (Stavosky et al., 1980) , or all three of these circadian rhythms . Studies in sighted subjects have supported these associations between sleepiness and melatonin (Akerstedt et al., 1979; Haimov et al., 1994; Tzischinsky et al., 1993) or between sleepiness and temperature (Akerstedt et al.,1979; Dijk and Czeisler, 1994; Strogatz et al., 1987) but have not proved any causative relationship.
The pineal hormone melatonin is considered a reliable marker of the circadian phase of the body clock (Arendt, 1995) . It can be accurately assessed indirectly by measuring the levels of its major urinary metabolite, 6-sulphatoxymelatonin (aMT6s), and is sensitive to phase shifts in melatonin production (Deacon and Arendt, 1994) . Urine can frequently and easily be collected for assay and is ideal for studies in patients' homes (Bojkowski et al., 1987) . Blind subjects provide a unique model to study the effects of a free-running circadian system on sleep. However, to our knowledge, there has been no previous attempt to quantify the periodicity or timing of daytime naps in free-running blind people, although their free-running nature was clear in an earlier report . The present study attempts to investigate the relationship between daytime napping and melatonin production, using aMT6s, in blind subjects.
METHODS AND DESIGN

Subjects
Subjects with no conscious light perception (NPL) were selected from a database compiled during an epidemiological study conducted at the Moorfields Eye Hospital in London (Tabandeh et al., 1995) . All subjects were clinically examined and visual acuity, duration, and severity of sight loss were recorded. The extent of any sleep disorder was assessed in a structured interview that included the Pittsburgh Sleep Quality Index (PSQI) (Buysse et al., 1989) . The PSQI is composed of seven components; subjective sleep quality, latency, duration, efficiency, disturbance, use of sleeping medication, and daytime dysfunction. These components contribute equally to a global PSQI score that has a possible range of 0-21 with a score of > 5 indicating a subjective sleep disorder. Subjects were excluded if they were taking any sleeping medication, antidepressants, benzodiazepines, fi blockers, or barbiturates.
A total of 15 subjects were studied (Table 1 ). The subjects were classified into three diagnostic groups: (1) both eyes intact (3 males, 2 females), (2) one eye intact (5 males), and (3) both eyes removed (5 males). During the study, 9 subjects were fully employed away from home and were required to work normal office hours. Of the 6 remaining subjects, 4 lived &dquo;conven-tional&dquo; days and had various social commitments, whereas 2 subjects were free to live as they wished and ordered their schedules to suit themselves. In all cases, no effort was made to alter their usual day-to-day routines.
Experimental Design
The subjects were studied for at least 4 weeks. Daily sleep diaries were kept recording bedtime, time of trying to sleep, latency, number and duration of night awakenings, wake-up and get-up times, and subjective sleep quality (9-point analog scale with 1 indicating best sleep ever and 9 indicating worst sleep ever). Sleep onset time was defined as the time sleep was attempted plus sleep latency Sleep offset time was defined as the wake-up time. Subjects also were asked to record any sleeping episodes outside their bedtime periods in a nap diary (time nap started and time nap ended). Data were provided and recorded on audio- Manchester) revealing the mean acrophase time or phi (~) for each 48-h window. To assess any change in the timing of aMT6s production, best-fit regression lines were fitted through the acrophases for each subject (period [i] = 24 h + slope). Similarly, regression lines also were fitted through the midpoint time of all naps and through the subjective sleep onset and offset times for each subject. An abrupt phase shift in sleep onset or offset was observed 4 times (from 30 analyses) in the raw data. For these analyses, the longest consecutive sequence of days was used to calculate the regression and is shown in Table 2. Periodicity was considered significantly different from 24 h when the 95% limits of the slope did not cross 0 (i.e., 24 h) and is expressed in decimal time.
The relationship between napping and aMT6s acrophase was investigated as follows. Using the midpoint time of all naps, naps were assigned to groups depending on whether they occurred within or outside a specified range before and after the daily aMT6s acrophase (calculated using regression). The number of naps occurring inside and outside this range was analyzed using paired Student's t test.
For those subjects (n = 4) whose free-running aMT6s rhythms passed through a normal phase (i.e., between 24:00 and 06:00 h) during the study, one-way analysis of variance (ANOVA) was used to compare the nap parameters (number and duration of daytime naps) during times when aMT6s was &dquo;in phase&dquo; (24:00 to 06:00 h) and &dquo;out of phase&dquo; (06:00 to 24:00 h) for each individual separately. To analyze the effect of aMT6s phase on sleep, sleep data were binned into hours corresponding to the estimated aMT6s acrophase time, calculated by extrapolation from the regression lines (3 to 7 data points, n = 4). These values then were grouped into four aMT6s phases (24:00 to 06:00, 06:00 to 12:00, 12:00 to 18:00, and 18:00 to 24:00 h) and were investigated using two-way ANOVA (subject and phase as factors) for night sleep duration, number and duration of naps, and sleep onset and sleep offset times.
The relationship between the duration of night sleep and napping was investigated by correlating the length of night sleep with the nap duration the following day for each subject.
RESULTS
The PSQI and Age
The main reasons for the subjects' sleep disorders, as revealed by the individual PSQI components, were re- Table 2 . Tau (i) of rhythm parameters (hours). NOTE: aMT6s = 6-sulphatoxymelatonin; dashes (-) represent parameters with taus not significantly different from 24 h. Where days are indicated, these days were used in the regression analysis (see Statistical Analysis subsection). duced night sleep duration, poor sleep quality, and daytime sleepiness. There were no significant differences in the age or PSQI scores between the three diagnostic groups: both eyes intact (age range 44-62 years, PSQI mean = 11.0 ± 3.0), one eye intact (age range 32-72 years, PSQI mean = 7.2 ± 4.5), and both eyes removed (age range 35-68 years, PSQI mean = 9.2 ± 5.0). Subjects who worked were significantly younger than those who did not work (workers, mean age = 44.7 ± 9.5, n = 9; nonworkers, mean age = 62.8 ± 8.3, n = 6; p < .05, unpaired Student's t test), although there was no difference between their PSQI scores (workers, mean PSQI = 8.8 ± 4.7, n = 9; nonworkers, PSQI = 9.7 ± 3.7, n = 6). There was a nonsignificant trend for subjects with free-running aMT6s rhythms to have higher PSQI scores than subjects with entrained aMT6s rhythms (mean PSQI = 9.9 ± 4.4, n = 9, and 8.0 ± 4.2, n = 6, respectively). There also was a nonsignificant trend for higher PSQI scores in subjects with abnormal aMT6s rhythms (mean PSQI = 9.9 ± 4.0, n = 12) compared to those in entrained subjects with normal rhythms (mean PSQI = 6.0 ± 4.4, n = 3). aMT6s Figure 1 shows the weekly aMT6s acrophase times for all subjects, grouped by pathology. Figure 1A shows that 4 subjects with both eyes removed had free-running aMT6s rhythms ('t range 24.39 to 24.68 h, p < .05). The other subject in Fig. 1A (S28) clearly was free-running without achieving statistical significance (T ± 95% limits = 24.41 ± 0.58 h) ( Table 2 ). Of the 5 subjects with one eye (Fig.1B) , 3 also had free-running aMT6s rhythms (i range 24.39 to 24.79 h). However, the other 2 subjects with one eye had normally entrained rhythms (mean aMT6s acrophase = 3.25 ± 0.53 Figure 2 . Relationship between naps and 6-sulphatoxymelatonin (aMT6s) acrophase. Figure shows the total number of naps within and outside a 4-h period before and after the calculated aMT6s acrophase for all subjects with abnormal rhythms, both individually and as a group (mean number of naps t SEM, n = 11). The vertical axis shows the total number of naps for the whole study.
The black columns represent the number of naps within the time range, and the gray columns represent the number of naps outside this range. There were significantly more naps within this 4-h range before and after the aMT6s acrophase than at any other time of day (**p < .01, n = 11). The 2 subjects with normally entrained aMT6s rhythms had more naps outside this range. and 2.10 ± 0.14 h). Of the 5 subjects with both eyes intact (Fig. 1C ),1 had a free-running rhythm (r = 24.34 h), 1 was normally entrained (mean aMT6s acrophase = 2.78 ± 0.51 h), and 3 were abnormally entrained (mean aMT6s acrophase = 14.3 ± 1.08, 20.3 ± 0.62, and 20.6 ± 0.06 h).
In summary, 9 of the 15 subjects had free-running aMT6s rhythms (i range 24.39 to 24.79 h), 3 had entrained but abnormally timed aMT6s acrophases, and 3 were normally entrained.
Naps
Most of the subjects (13 of 15) had daytime naps. The 2 individuals who did not nap reportedly made a conscious effort not to do so. Of these 2 subjects, 1 had a normally entrained aMT6s rhythm (S25, Fig. 1C ), and the other 1 was abnormally entrained (S22, Fig.  1C ). These 2 subjects were excluded from further nap analysis. There were no differences in the number or duration of naps per day between subjects who did or did not work. On Days 22 and 23 in Panel A, sleep occurred but was not recorded by the subject.
Of the subjects with free-running aMT6s rhythms, 3 also had free-running nap rhythms (i = 24.22, 24.23, and 24.26 h) . Their corresponding tau values for Table 3 . Mean numbers and durations (± 5Ds) of naps in and out of a normal 6-sulphatoxymelatonin phase. *Compared to in phase (p < .05, one-way ANOVA). aMT6s (i = 24.39, 24.79, and 24.68 h, respectively) were substantially longer. A further subject (S26) with a free-running aMT6s rhythm also had a free-running nap rhythm just outside the 95% confidence limit for statistical significance (aMT6s i ± 95% limits = 24.39 ± 0.34 h, nap 1 = 24.19 ± 0.23 h) ( Table 2) .
Relationship between Naps and aMT6s
On average, 54% of all daytime naps occurred within a 4-h range before and after the estimated daily aMT6s acrophase (n = 13, p > .1, ns, paired Student's t test). However, in subjects with abnormal aMT6s rhythms (n = 11), significantly more naps (63%) occurred within the 4-h range before and after the aMT6s acrophase (p < .01, paired Student's t test) (Fig. 2) . In free-running aMT6s subjects only (n = 9), 61% of all naps occurred within this range (p < .01, paired Student's t test). In subjects with abnormally entrained aMT6s acrophases (n = 3), the 2 subjects who napped demonstrated similarities between the timing of the aMT6s acrophase and the timing of daytime naps (mean aMT6s acrophase =14.30 ± 1.08 and 20.30 ± 0.62 h, mean nap time = 14.01 ± 3.60 and 18.23 ± 3.20 h, respectively). Naps were significantly longer (p < .01, unpaired Student's t test) and tended to be more frequent in subjects with abnormal aMT6s rhythms (n = 11) compared to normally entrained subjects (n = 2). Figure 3 shows the relationship between naps, sleep onset and offset times, and aMT6s rhythms in 3 representative blind subjects, 2 with free-running rhythms and 1 with an abnormally entrained aMT6s rhythm.
Relationship between Naps, Sleep, and aMT6s Phase Position
To evaluate the relationship between free-running aMT6s rhythms and both daytime and nighttime sleep, the free-running subjects with aMT6s acro-phases passing (at least partially) through both a normal phase (24:00 to 06:00 h) and an abnormal phase were investigated (n = 4). All 4 subjects had fewer naps per day and a reduced daily nap duration when aMT6s was in a normal phase compared to when aMT6s was in an abnormal phase ( Table 3 ). The group relationship between aMT6s acrophase and nap duration and number is shown in Fig. 4 . Figure 5 shows the group variations in sleep parameters (night sleep duration, onset, and offset) in relation to changes in aMT6s phase in these 4 free-running subjects. The duration of nighttime sleep was increased (but not significantly) when the aMT6s was in a normal phase (24:00 to 06:00 h) compared to all other phases. Sleep onset showed a significant variation as a function of aMT6s phase (two-way ANOVA, p < .05). Onset times delayed when the aMT6s was in a delaying position (06:00 to 12:00 h) according to the phase-response curve for exogenous melatonin , and they advanced when the aMT6s was in an advancing position (18:00 to 24:00 h). Similarly, sleep offset times also varied between phases with a nonsignificant trend to advance when the aMT6s was in an advancing position.
The relationship between night sleep duration and nap duration the following day was evaluated, and there were 4 out of 12 significant negative correlations between the duration of night and day sleep (r range = -.36 to -.78). One subject failed to keep proper records of sleep lost during the night and was excluded from these analyses. Of the remaining 8 subjects, 6 showed a nonsignificant negative trend (r < -.23).
aMT6s and Sleep Periodicity
When sleep parameters (sleep onset and offset) free ran, they only free ran in subjects with free-running aMT6s rhythms (Table 2 ). In all cases, their periodicities were reduced relative to the aMT6s rhythms (aMT6s 1 range = 24.39 to 24.79 h, sleep parameters 1 
DISCUSSION
This study demonstrates a high incidence of daytime naps in blind subjects without light perception. The timing of these naps has not been investigated previously. In addition, our field study quantifies for the first time the periodicity of free-running nap rhythms in several blind subjects in relation to their aMT6s and sleep rhythms. (B) sleep onset times (in hours), and (C) sleep offset times (in hours) in relation to the daily aMT6s acrophase times in 4 free-running subjects. The results are expressed over one 24-h period (means ± SEMs). The horizontal axis shows the hour of the calculated daily aMT6s acrophase. The shaded areas represent the time over which the phase position of the aMT6s rhythm is considered normal, according to studies of sighted subjects. An increase in night sleep duration (A) was seen when the aMT6s was in a normal phase. There was a trend for sleep onset and offset times to delay when the aMT6s was in a delaying phase (06:00 to 12:00 h) and to advance when the aMT6s was in an advancing phase (18:00 to 24:00 h), in accordance with the phase-response curve for exogenous melatonin administration.
Free-running naps occurred only in subjects with free-running aMT6s rhythms and therefore a freerunning endogenous body clock. The periodicity of the nap rhythm was shorter than the endogenous aMT6s rhythm, probably due to the masking effects of attempting to live a conventional 24-h lifestyle. This masking also was observed in the other behavioral measures of sleep onset and offset times. It is remarkable that the free-running nap component was measurable at all, particularly when all 4 subjects with free-running naps were fully employed with conventional working hours. This suggests that the endogenous influence controlling the need to nap is very strong in these subjects and is very difficult to consciously override. However, this influence must vary between individuals because there were subjects with free-running aMT6s rhythms who exhibited non-freerunning naps. A possible explanation is that these subjects were unable to take sleep at the required times, delaying their naps until more convenient times. Of the 9 subjects who worked, 7 had free-running aMT6s rhythms; this suggests that any masking effects of social time cues are more likely to influence behavioral rhythm parameters than to influence the aMT6s rhythm.
The timing of naps was consistent with the position of the aMT6s acrophase in most subjects regardless of whether the aMT6s rhythm was free-running or abnormally entrained. Significantly more naps occurred within a 4-h range before and after the estimated aMT6s acrophase. This time interval corresponds to the time during which normal endogenous melatonin levels are elevated (Bojkowski et al., 1987) . The relationship between napping and aMT6s was especially clear in the 2 subjects who napped and had abnormally timed but stable aMT6s acrophases. This finding suggests either that endogenous melatonin itself is having an effect (direct or indirect) on the induction of sleepiness or that endogenous melatonin is a coincidental phase marker of another unconnected factor inducing sleep.
It could be suggested that these naps are just &dquo;com-pensatory&dquo; naps for poor night sleep. If this were the case, then the timing of naps would be irregular and would especially not reflect the free-running pattern of aMT6s production. The distribution of the naps, however, was not irregular; it was clustered around times of peak aMT6s production. Subjects who could theoretically nap at any time of day napped at times when aMT6s levels were high, not necessarily when it was most convenient.
The finding in 4 subjects that there was a significant negative correlation between night sleep and nap duration the following day supports the theory that sleep is under circadian control. In a free-running individual, as aMT6s phase becomes abnormally timed and aMT6s production peaks during the day, night sleep duration decreases. Simultaneously, naps occur during times of high daytime aMT6s and nap duration increases, yielding a negative correlation. The variation in the ability to sleep during different circadian phases is illustrated in circadian desynchrony studies (Dijk and Czeisler, 1994) and is further demonstrated in these free-running subjects in the field.
It is clear that the timing of naps and sleep is under the control of the endogenous body clock, and so the question remains as to how the clock exerts its effect on sleep induction and maintenance. Endogenous melatonin has been shown to have a strong association with sleep propensity in a 64-h constant routine of sighted subjects (Akerstedt et al., 1979) . In a free-running blind subject, sleep propensity, temperature, and cortisol free ran in parallel with melatonin, with sleep propensity rising and falling with melatonin levels . Tzischinsky et al. (1993) demonstrated that the opening of the &dquo;sleep gate,&dquo; allowing nighttime sleep, is strongly correlated with the onset of aMT6s secretion in sighted subjects. They suggested that either a &dquo;critical accumulation&dquo; of melatonin is needed to initiate sleep or, more specifically, the onset of melatonin may open the sleep gate.
Our results agree with these studies and show most naps occurring in a 4-h window before and after the aMT6s acrophase.
Abnormalities of melatonin production also have been implicated in causing sleep disorders. Haimov et al. (1994) found a correlation between disturbed and low levels of aMT6s secretion with sleep disorders in sighted elderly subjects. Much of the work with the blind has recorded the association between abnormally timed and free-running melatonin production with sleep disorders (Aldhous and Arendt, 1991; Arendt et al., 1988; Lewy and Newsome, 1983; Sack et al., 1987; Tzischinsky et al., 1991) . Our study has confirmed this relationship. Both free-running and abnormally entrained subjects who failed to pass through a normal phase (24:00 to 06:00 h) during the study clearly demonstrated sleep disturbances while the aMT6s was in an abnormal phase. The subjects who free ran through both a normal and an abnormal phase demonstrated increased night sleep duration and a reduction in the number and duration of day-time sleeping episodes when the aMT6s acrophase was out of a normal phase position. There was a trend for the sleep onset times to delay and for both sleep onset and offset times to advance when the aMT6s was in a delaying and an advancing position, respectively (06:00 to 12:00 and 18:00 to 24:00 h, respectively, in accordance with the phase-response curve for exogenous melatonin administration ).
There is further evidence to support an influential role of melatonin in sleep from the extensive studies on the effects of exogenous melatonin administration in sighted subjects. In both pharmacological (Arendt et al., 1984; Dollins et al., 1993; Lieberman et al., 1984; Macfarlane et al., 1991 ; Nave et al., 1995; Vollrath et al., 1981) and physiological doses (Dollins et al., 1994) , rnelatonin has a sleepiness-inducing effect at various times of the day, although not all studies are consistent (James et al., 1990) . Exogenous melatonin administration to the blind also has provided ambiguous results. When timed correctly, melatonin has stabilized and improved night sleep and has abolished day sleep Jan et al.,1994; Okawa et al.,1987; Palm et al., 1991 ; Sarrafzadeh et al., 1990 ; Tzischinsky et al., 1992) , although not in all cases (Aldhous and Arendt, 1991) . Whether melatonin acts through its acute effects on alertness and/or temperature (Deacon and Arendt, 1995) or through its phase-shifting properties still is unclear (Arendt et al., 1984) .
In a wider context, this study provides a basis on which the integrity of the retinohypothalamic tract (RHT) may be predicted. We may assume that freerunning subjects do not have an intact RHT and that the tau measured is the endogenous phase. However, assumptions cannot be made about the RHT of normally or abnormally entrained subjects, especially in view of recent findings implicating nonphotic zeitgebers in the entrainment of melatonin rhythms in the blind (Czeisler et al., 1995) . It is important that future work test whether entrainment is mediated by photic or nonphotic zeitgebers, for example, by testing the ability of bright light to suppress endogenous melatonin production in these subjects (Lewy et al., 1980) . This study demonstrates the relationship between daytime melatonin and daytime sleep episodes. It also provides further evidence to support a causal effect of melatonin on the induction of sleepiness, whether through direct or indirect mechanisms. Furthermore, it stresses the need for allowing and recording spontaneous napping in circadian rhythm disorder studies. Blind subjects provide an excellent and highly moti-vated &dquo;model&dquo; to investigate the complex homeostatic mechanisms and circadian influences of endogenous rhythms on daytime sleep.
